Endocytosis in cancer and cancer therapy

B Banushi, SR Joseph, B Lum, JJ Lee… - Nature Reviews …, 2023 - nature.com
Endocytosis is a complex process whereby cell surface proteins, lipids and fluid from the
extracellular environment are packaged, sorted and internalized into cells. Endocytosis is …

Mechanisms of resistance to antibody–drug conjugates

RO Abelman, B Wu, LM Spring, LW Ellisen, A Bardia - Cancers, 2023 - mdpi.com
Simple Summary Antibody–drug conjugates (ADCs) are a growing class of therapies that
aim to delivery therapy more efficiently, with fewer side effects, than conventional …

Resistance to antibody-drug conjugates targeting HER2 in breast cancer: molecular landscape and future challenges

L Guidi, G Pellizzari, P Tarantino, C Valenza… - Cancers, 2023 - mdpi.com
Simple Summary Human epidermal growth factor receptor 2 (HER2)-positive metastatic
breast cancer (mBC) represents a subgroup of breast cancer characterized by an …

Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers

Y Rao, Z Samuels, LM Carter… - Proceedings of the …, 2023 - National Acad Sciences
Human epidermal growth factor receptor 2 (HER2) is overexpressed in various cancer types.
HER2-targeting trastuzumab plus chemotherapy is used as first-line therapy for HER2 …

Immuno-PET Detects Antibody–Drug Potency on Coadministration with Statins

EL Brown, S Shmuel, K Mandleywala… - Journal of Nuclear …, 2023 - Soc Nuclear Med
The human epidermal growth factor receptor 2 (HER2)–targeting trastuzumab emtansine (T-
DM1) and trastuzumab deruxtecan (T-DXd) are antibody–drug conjugates (ADC) clinically …

PET and optical imaging of caveolin-1 in gastric tumors

S Surendra Panikar, S Shmuel, JS Lewis… - ACS …, 2023 - ACS Publications
Previous studies have suggested tumoral caveolin-1 (CAV1) as a predictive biomarker for
the response to anti-HER2 antibody drug therapies in gastric tumors. In this study …

Caveolin-1 knockout mitigates breast cancer metastasis to the lungs via integrin α3 dysregulation in 4T1-induced syngeneic breast cancer model

DP Singh, R Pathak, N Chintalaramulu, A Pandit… - Cancer Gene …, 2024 - nature.com
Abstract Caveolin-1 (Cav-1) is a critical lipid raft protein playing dual roles as both a tumor
suppressor and promoter. While its role in tumorigenesis, progression, and metastasis has …

[HTML][HTML] Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities

W Jiang, WL Jin, AM Xu - International Journal of Biological …, 2024 - ncbi.nlm.nih.gov
Cholesterol is crucial for cell survival and growth, and dysregulation of cholesterol
homeostasis has been linked to the development of cancer. The tumor microenvironment …

Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort study

F Usefi, A Rustamzadeh, Z Ghobadi, N Sadigh… - Metabolic Brain …, 2024 - Springer
Abstract microRNAs are candidate diagnostic biomarkers for Alzheimer's disease. This study
aimed to compare Silymarin with Rosuvastatin and placebo on total-Tau protein level and …

PDX Models in Theranostic Applications: Generation and Screening for B Cell Lymphoma of Human Origin

S Shmuel, S Monette, D Ibrahim… - Molecular Imaging and …, 2024 - Springer
This MIB guide briefly summarizes the generation of patient-derived xenografts (PDXs) and
highlights the importance of validating PDX models for the presence of B cell lymphoma of …